Sun Pharmaceutical Industries Ltd.
ShareSUNPHARMA Competitor Analysis
| SUNPHARMA | DIVISLAB  | TORNTPHARM | CIPLA | DRREDDY | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 21 Nov, 2025, 02:09 PM | 1,784.50 0% | 6,412.50 0% | 3,699.10 0% | 1,522.50 0% | 1,246.90 0% |
| Market cap (₹ Cr) | 4,28,161 | 1,70,232 | 1,25,194 | 1,22,981 | 1,04,064 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -0.29% | -0.69% | -0.75% | -1.37% | -0.05% |
| 1W | 1.54% | -0.71% | -0.88% | -0.32% | 1.15% |
| 1M | 4.16% | -1.98% | 6.17% | -7.6% | -2.98% |
| 3M | 7.7% | 7.8% | 3.47% | -2.04% | -0.13% |
| 6M | 2.99% | 0.33% | 16.95% | 4.13% | 1.6% |
| 1Y | -1.04% | 9.7% | 22.49% | 2.92% | 2.5% |
| 5Y | 249.49% | 86.6% | 190.49% | 104.69% | 33.14% |
Income StatementAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% | 32,644 16.54% |
| OPM (%) | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% | 25.33 -7.72% |
| PBT | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% | 7,658 6.57% |
PAT | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% | 5,704 2.53% |
| Net Profit Margin | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% | 17.54 -11.9% |
| EPS | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% | 67.81 -79.72% |
Balance Sheet & Cash FlowAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% | 33,550 18.74% |
| Total Assets | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% | 49,427 27.18% |
| Total Outside Liabilities | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% | 15,877 49.66% |
| Cash from Operating Activity | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% | 4,643 2.2% |
| Cash from Investment Activity | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% | -5,808 -44.19% |
| Cash from Financing Activity | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% | 1,891 602.52% |
| Net Cash Flow | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% | 748.6 463.7% |
RatiosAnnual data as on 13 Dec 2025. | |||||
| PB | 5.77 | 10.22 | 14.42 | 3.73 | 2.84 |
| PE | 39.18 | 77.70 | 65.50 | 23.32 | 18.40 |
| ROE (%) | 16.16 | 15.35 | 26.46 | 18.28 | 18.46 |
| Dividend Yield (%) | 0.90 | 0.47 | 0.87 | 1.05 | 0.64 |
| ROCE (%) | 20.86 | 20.45 | 27.55 | 23.64 | 23.48 |
